Clinical trial
DOCICAR: Cardiac Dysfunction in Cirrhosis
NCT00250315 · Hvidovre University Hospital, Other · Completed
Key facts
| NCT number | NCT00250315 |
|---|---|
| Title | DOCICAR: Cardiac Dysfunction in Cirrhosis |
| Official title | Cardiac Dysfunction in Cirrhosis: Cirrhotic Cardiomyopathy Evaluated by Dobutamin MRI. |
| Lead sponsor | Hvidovre University Hospital, Other |
| Status | Completed |
| Study type | Observational |
| Conditions | Cirrhosis, Cirrhotic Cardiomyopathy |
| Intervention type | Drug |
| Interventions | Dobutamine |
| Start date | Nov 1, 2005 |
| Completion | Oct 1, 2007 |
| First posted | Nov 8, 2005 |
| Last update posted | Nov 1, 2007 |
| Countries | Denmark |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: